Ligand validation:5IGV

GDP: GUANOSINE-5'-DIPHOSPHATE

GDP is a Ligand Of Interest in 5IGV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IGV_GDP_A_403	80%	49%	0.087	0.936	0.82	1.13	-	2	4	0	100%	0.9529
5IH1_GDP_A_401	98%	58%	0.055	0.977	0.84	0.77	-	-	0	0	100%	1
5IGY_GDP_A_402	98%	50%	0.06	0.982	1.01	0.92	1	1	0	0	100%	1
5IGZ_GDP_A_401	96%	51%	0.079	0.986	0.67	1.2	-	3	0	0	100%	1
5IGW_GDP_A_401	73%	46%	0.111	0.937	1.05	1.04	2	3	0	0	100%	0.94
5IH0_GDP_A_403	41%	45%	0.148	0.86	0.91	1.19	-	4	1	0	100%	0.9643
1RRG_GDP_A_183	100%	17%	0.036	0.997	2.05	1.56	7	3	0	0	100%	1
2CXX_GDP_B_2401	100%	29%	0.031	0.989	1.26	1.57	1	3	0	0	100%	1
4LUC_GDP_A_204	100%	40%	0.036	0.992	1.22	1.11	2	2	0	0	100%	1
5YMX_GDP_A_301	100%	54%	0.038	0.994	0.92	0.85	1	-	2	0	100%	1
5KY2_GDP_A_403	100%	48%	0.036	0.989	0.98	1.04	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.